GSK PLC SP. ADR/2 NEW Working Capital to Net Assets Ratio
GSK PLC SP. ADR/2 NEW working capital to net assets ratio. GSK PLC SP. ADR/2 NEW (GS70) has a Working Capital to Net Assets ratio of -23.1% as of June 2026. Working capital of €-3.98 Billion (current assets of €17.56 Billion minus current liabilities of €21.53 Billion) is measured against net assets of €17.18 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check GS70 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of GSK PLC SP. ADR/2 NEW (2021–2025)
Working capital to net assets ratio of GSK PLC SP. ADR/2 NEW from 2021 to 2025. This chart shows how GSK PLC SP. ADR/2 NEW's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at -23.1%, reflecting working capital of €-3.98 Billion against net assets of €17.18 Billion EUR. See GS70 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
GSK PLC SP. ADR/2 NEW Working Capital to Net Assets Ratio by Year (2021–2025)
GSK PLC SP. ADR/2 NEW working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for GSK PLC SP. ADR/2 NEW from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see GSK PLC SP. ADR/2 NEW balance sheet assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -24.3% | €-3.88 Billion | €15.96 Billion | €17.51 Billion | €21.39 Billion | ▲ +11.6 pp |
| 2024 | -35.9% | €-4.70 Billion | €13.09 Billion | €17.00 Billion | €21.70 Billion | ▼ -17.0 pp |
| 2023 | -18.9% | €-2.42 Billion | €12.79 Billion | €18.64 Billion | €21.07 Billion | ▲ +1.3 pp |
| 2022 | -20.2% | €-2.04 Billion | €10.10 Billion | €20.77 Billion | €22.81 Billion | ▲ +3.2 pp |
| 2021 | -23.4% | €-5.00 Billion | €21.34 Billion | €18.67 Billion | €23.67 Billion | — |